What is it about?
Superbug E.coli ST131 has emerged as a pandemic lineage of important multidrug resistant pathogens worldwide. It has become a major cause of antibiotic-resistant urinary tract and bloodstream infections. Despite many epidemiological studies, no has reported specific ST131 biofilm-promoting factors. Here we have shown biofilm formation by diverse ST131 isolates under different biologically-relevant conditions, including urine from healthy adult women. We have identified type 1 fimbriae as the critical determinant for biofilm formation by ST131. Type 1 fimbriae are finger-like projections on E. coli surface and are essential for sticking to human tissues to initiate infection. We also found that if we block the fimbriae with specific inhibitors, ST131 can no longer form biofilms.
Featured Image
Why is it important?
Superbugs are becoming extremely difficult to treat clinically due to their growing repertoire of antibiotic-resistance factors. This problem is further compounded in biofilms where these pathogens form tightly-knit communities that are hard to eliminate even in antibiotic-susceptible populations. Biofilms can form within the body and also on invasive surgical instruments, in-dwelling medical implants and diagnostic devices. This is the first study of superbug ST131 biofilm formation under biologically relevant conditions and paves the way for the application of specific adhesion-inhibitors in treating drug resistant ST131 biofilm infections.
Perspectives
Read the Original
This page is a summary of: Biofilm formation by multidrug resistant Escherichia coli ST131 is dependent on type 1 fimbriae and assay conditions , Pathogens and Disease, March 2016, Oxford University Press (OUP),
DOI: 10.1093/femspd/ftw013.
You can read the full text:
Resources
Contributors
The following have contributed to this page